TickerFacts.

Quest Diagnostics Inc (DGX): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

$2.13B
Year ended 2025-12-31
$2.21B
Trailing 12 months to 2026-06-30
+4.5%
3-year compound annual growth
-1.8%
5-year compound annual growth
+2.2%
10-year compound annual growth
$2.79B2007-12-31: $1.33B2008-12-31: $1.49B2009-12-31: $1.62B2010-12-31: $1.54B2011-12-31: $1.27B2012-12-31: $1.49B2013-12-31: $1.76B2014-12-31: $1.30B2015-12-31: $1.70B2016-12-31: $1.53B2017-12-31: $1.44B2018-12-31: $1.41B2019-12-31: $1.56B2020-12-31: $2.33B2021-12-31: $2.79B2022-12-31: $1.86B2023-12-31: $1.70B2024-12-31: $1.84B2025-12-31: $2.13B$2.13B
2007-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$2.13B+15.6%2026-02-26, From 2025-01-01
2024-12-31$1.84B+8.1%2026-02-26, From 2024-01-01
2023-12-31$1.70B-8.8%2026-02-26, From 2023-01-01
2022-12-31$1.86B-33.1%2025-02-20, From 2022-01-01
2021-12-31$2.79B+19.6%2024-02-22, From 2021-01-01
2020-12-31$2.33B+49.5%2023-02-21, From 2020-01-01
2019-12-31$1.56B+10.6%2022-02-28, From 2019-01-01
2018-12-31$1.41B-1.7%2021-02-22, From 2018-01-01
2017-12-31$1.44B-6.0%2020-02-20, From 2017-01-01
2016-12-31$1.53B-10.4%2019-02-21, From 2016-01-01
2015-12-31$1.70B+31.3%2018-02-23, From 2015-01-01
2014-12-31$1.30B-26.2%2017-02-22, From 2014-01-01
2013-12-31$1.76B+18.1%2016-02-26, From 2013-01-01
2012-12-31$1.49B+17.4%2015-02-24, From 2012-01-01
2011-12-31$1.27B-17.5%2014-02-18, From 2011-01-01
2010-12-31$1.54B-4.8%2013-02-27, From 2010-01-01
2009-12-31$1.62B+8.7%2012-02-16, From 2009-01-01
2008-12-31$1.49B+11.9%2011-02-16, From 2008-01-01
2007-12-31$1.33Bn/a2010-02-17, From 2007-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Quest Diagnostics Inc (DGX)2025-12-31$2.13B+15.6%
Labcorp Holdings Inc. (LH)2025-12-31$2.07B+19.4%
Fortrea Holdings Inc. (FTRE)2025-12-31-$794.60Mn/m
Natera, Inc. (NTRA)2025-12-31-$268.15Mn/m
RadNet, Inc. (RDNT)2025-12-31$198.09M-13.8%
Guardant Health, Inc. (GH)2025-12-31-$397.51Mn/m
Caris Life Sciences, Inc. (CAI)2025-12-31$67.73Mn/m
Veracyte, Inc. (VCYT)2025-12-31$79.19M+100.0%
CareDx, Inc. (CDNA)2025-12-31-$15.76Mn/m

Compare DGX, LH, FTRE, NTRA side by side · Screen every company in Services-Medical Laboratories ↗